BIIB vs LXFR · P/E 21, rev $9.89B vs P/E 16, rev $181.4M
Biogen Inc (BIIB) versus Luxfer Holdings PLC (LXFR) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Luxfer Holdings PLC (LXFR) is a specialty industrial machinery company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported LXFR revenue for 2026-06-28 was $181.4M. Net income was $8.4M. LXFR currently screens at market cap $345.4M and trailing P/E 16.3.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. LXFR currently screens at market cap $345.4M and trailing P/E 16.3.
Not investment advice. Open the BIIB and LXFR stock pages for the full models.
Not investment advice.